ArticleAdvances in radiation oncology2025

Prospective Phase II Trial of Definitive Chemoradiation and Concurrent Nivolumab in Locally Advanced p16+ Oropharynx Cancer.

Samuel Nicholas Regan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.